409A valuation AI Medical Service AOT asset valuation Biotech firms Biotechgate Biotechgate Digital Partnering brain activity measuring breast cancer Cells clinical trial database Cold Ablation Robotguided Laser Osteotome cranio-maxillofacial surgery Cyrill Bätscher early digestive track cancer detection Ferring Pharmaceutical filming Fujieda Ayumi Funding future of life sciences Gergely Ivanyi German Biotech German Life Sciences GTAI Health Made in Germany Heartseed Inc. HelloPartnering in-licensing opportunities JPM San Francisco Kiyoshi Hasegawa life science database Lily MedTech Inc. medical image analysis NeU Corporation patrik frei product valuation RESI Rhine-Main-Neckar biotech SARS CoV 2 Shiho Azuma Tomohiro Tada valuation Valuation Experts XB-01 Yone Production Co Ltd
April 2021: Started in Basel by three experienced Partners, Forty51 Ventures targets seed and early-stage investments in underfunded Biotech clusters in Switzerland, Germany, Eastern France, Northern Italy, and Austria.
Venture Valuation (VV) interviewed Sascha Oliver Bucher, Co-Founder and Partner.
Would you like to be notified about new interviews, reports and other valuable content published by Venture Valuation?